Editorial response: Discordance between virological, immunologic, and clinical outcomes of therapy with protease inhibitors among human immunodeficiency virus-infected patients

被引：6
|
作者：
Goetz, MB
机构：
[1] Vet Adm Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA 90073 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
来源：
CLINICAL INFECTIOUS DISEASES | 1999年 / 29卷 / 06期
关键词：
D O I：
10.1086/313563
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1431 / 1434
页数：4
相关论文
共 50 条
  • [41] The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials
    Mannheimer, S
    Friedland, G
    Matts, J
    Child, C
    Chesney, M
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) : 1115 - 1121
  • [42] Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients
    King, JR
    Acosta, EP
    Chadwick, E
    Yogev, R
    Crain, M
    Pass, R
    Kimberlin, DW
    Sturdevant, MS
    Aldrovandi, GM
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (03) : 239 - 244
  • [43] Changing epidemiology of nosocomial infections in human immunodeficiency virus-infected patients - Response
    Kuehnert, MJ
    Jarvis, WR
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (02) : 321 - 323
  • [44] Antigenaemia and antibody response to Toxoplasma gondii in human immunodeficiency virus-infected patients
    Malla, N
    Sengupta, C
    Dubey, ML
    Sud, A
    Dutta, U
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2005, 62 (01) : 19 - 23
  • [45] Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients
    Wang, Tianwei
    Gao, Ting
    Niu, Xiaodong
    Xing, Xiao
    Yang, Yuan
    Liu, Yanhui
    Mao, Qing
    WORLD NEUROSURGERY, 2018, 114 : E218 - E223
  • [46] Distinct Clinical Characteristics of Myelodysplastic Syndrome in Human Immunodeficiency Virus-Infected Patients
    Takahashi, Koichi
    Yabe, Mariko
    Shapira, Ilan
    Verma, Mala
    BLOOD, 2011, 118 (21) : 1632 - 1633
  • [47] Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis. (vol 30, pg 779, 2000)
    Narita, M
    Stambaugh, JJ
    Hollender, ES
    Jones, D
    Pitchenik, AE
    Ashkin, D
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (06) : 992 - 992
  • [48] Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents
    Siberry, George K.
    Coller, Ryan J.
    Henkle, Emily
    Kiefner, Carolyn
    Joyner, Mary
    Rogers, Jamie
    Chang, Jennifer
    Hutton, Nancy
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (05) : 465 - 468
  • [49] Response to changes in antiretroviral therapy after genotyping in human immunodeficiency virus-infected children
    Cohen, NJ
    Oram, R
    Elsen, C
    Englund, JA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (07) : 647 - 653
  • [50] Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients
    Solas, C
    Lafeuillade, A
    Halfon, P
    Chadapaud, S
    Hittinger, G
    Lacarelle, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 238 - 243
12345